scPharmaceuticals

About:

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Website: http://www.scpharmaceuticals.com/

Twitter/X: scPharmaUSA

Top Investors: Silicon Valley Bank, OrbiMed, Perceptive Advisors, 5AM Ventures, Lundbeckfonden Ventures

Description:

ScPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two-component delivery system suitable for patient self-administration. In February 2013 scPharmaceuticals was formed to continue the groundbreaking work of SpringLeaf Therapeutics, a Boston area company that started in 2007. scPharmaceuticals targets the untapped opportunity of treating patients with serious medical conditions with a convenient safe and comfortable subcutaneous administration of a drug. This is therapeutically equivalent to intravenous administration while avoiding the cost, burden, and risks associated with intravenous administration.

Total Funding Amount:

$457M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)scpharma.com

Founders:

Pieter Muntendam

Number of Employees:

11-50

Last Funding Date:

2024-08-12

IPO Status:

Public

© 2025 bioDAO.ai